glp-1 pancreatitis class action in kentucky Frontiers Dose-dependent pancreatitis risk associated with
Description
Intranasal delivery of glucagon-like peptide-1 to the brain for obesity treatment: opportunities and challenges
It can influence renal function by increasing diuresis and natriuresis, and it can impact cardiac function by enhancing contractility and promoting cardiomyocyte survival
Over the counter or unsupervised versions can lead to nutrient deficiencies, muscle loss, and long term rebound weight gain
Compounding pharmacies are particularly vulnerable, as many source hormone powders internationally
it's a sign that adaptation is still occurring
Available from: Accessed 28 June 2025 Marso SP, Bain SC, Consoli A, et al
